mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1
about
The synthesis of truncated polypeptides for immune surveillance and viral evasion.Epstein Barr virus-encoded EBNA1 interference with MHC class I antigen presentation reveals a close correlation between mRNA translation initiation and antigen presentation.Nucleolin directly mediates Epstein-Barr virus immune evasion through binding to G-quadruplexes of EBNA1 mRNAG-quadruplexes regulate Epstein-Barr virus-encoded nuclear antigen 1 mRNA translation.mRNA Structural constraints on EBNA1 synthesis impact on in vivo antigen presentation and early priming of CD8+ T cells.Messenger RNA sequence rather than protein sequence determines the level of self-synthesis and antigen presentation of the EBV-encoded antigen, EBNA1.Major source of antigenic peptides for the MHC class I pathway is produced during the pioneer round of mRNA translation.Effects of APC De-targeting and GAr modification on the duration of luciferase expression from plasmid DNA delivered to skeletal muscleLatent Membrane Protein LMP2A Impairs Recognition of EBV-Infected Cells by CD8+ T Cells.A yeast-based assay identifies drugs that interfere with immune evasion of the Epstein-Barr virus.Evasion of adaptive and innate immune response mechanisms by γ-herpesviruses.The Epstein-Barr Virus EBNA1 Protein.Epstein-Barr virus-encoded EBNA1 and ZEBRA: targets for therapeutic strategies against EBV-carrying cancers.The long-lasting love affair between the budding yeast Saccharomyces cerevisiae and the Epstein-Barr virus.Cap-independent translation ensures mTOR expression and function upon protein synthesis inhibition.Proteasome inhibitors induce the presentation of an Epstein-Barr virus nuclear antigen 1-derived cytotoxic T lymphocyte epitope in Burkitt's lymphoma cells.The central repeat domain 1 of Kaposi's sarcoma-associated herpesvirus (KSHV) latency associated-nuclear antigen 1 (LANA1) prevents cis MHC class I peptide presentation.High avidity binding to DNA protects ubiquitylated substrates from proteasomal degradation.Autophagy and immunity - insights from human herpesvirusesModelling the structure of full-length Epstein-Barr virus nuclear antigen 1.Developing a potentially immunologically inert tetracycline-regulatable viral vector for gene therapy in the peripheral nerve.Macavirus latency-associated protein evades immune detection through regulation of protein synthesis in cis depending upon its glycin/glutamate-rich domain.PI3Kδ activates E2F1 synthesis in response to mRNA translation stress.EBNA1: Oncogenic Activity, Immune Evasion and Biochemical Functions Provide Targets for Novel Therapeutic Strategies against Epstein-Barr Virus- Associated Cancers.Remodeling of the epitope repertoire of a candidate idiotype vaccine by targeting to lysosomal degradation in dendritic cells
P2860
Q33526302-2CD36704-D367-4DFE-AFC6-B39A5D3F2FE9Q33728510-2D776EAA-5AC1-47D5-9B45-E2E37AE46792Q33891292-B09B78C7-B9DE-4868-8F26-E12E489C11AEQ34303299-60953629-9674-4F5F-B10D-5849D9209A5DQ34317937-4F58C081-CA89-49DB-8887-C5CB67CC33B8Q34539792-B458C838-DCF3-477D-A1A7-002C67AFB6E0Q35105327-6F57E0D9-E6C5-40E0-8DF3-874DB25CE9E0Q35646675-0FDBE766-21FC-4469-8E1D-5AE3E6890A0DQ35661383-B749F4F4-4764-4B5A-AA7C-AEB0B0DA903AQ37682377-5E5A7A8E-BDCB-44FC-BAA6-88A0FBDB508EQ38111863-0271CCDD-E246-42D9-943C-AAEEF80EE4D3Q38166365-601E5BA6-A8EA-4C8B-BF28-DB38C6764323Q38245881-020330EB-D417-4E74-9860-A8B66DA73670Q38574687-84475237-AAD4-47F6-920D-B715AF93309FQ38618035-5C7985F6-4306-4769-A507-BE4950285F0CQ39588027-E9380A1B-045D-40A5-96FE-844FBE3D6BF9Q39591598-14CB8064-388A-48F6-94EB-3BEAA2D6D0BBQ41894692-7961D35E-8F66-4F4A-909E-78EC106FCCEEQ42185618-33E957FD-FBEF-459E-8DA2-276E3D00944FQ42206678-45C30C50-11CE-4F82-A9AC-0559A6612B54Q42227411-CBEAAB61-12FB-4F93-B3DC-898DB6B86A2AQ46277344-7280A08B-EFC4-47E9-B7E5-9EE35A54A8FFQ47117105-741872D9-1837-45D5-937D-17A1BEA842FAQ52593708-2C02885C-16F6-4F5D-818C-CFD9B9A0D82BQ57056029-03151283-9A37-45DF-963C-EB63E0CC5EEB
P2860
mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1
@en
mRNA translation regulation by ...... -Barr virus nuclear antigen 1.
@nl
type
label
mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1
@en
mRNA translation regulation by ...... -Barr virus nuclear antigen 1.
@nl
prefLabel
mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1
@en
mRNA translation regulation by ...... -Barr virus nuclear antigen 1.
@nl
P2093
P2860
P356
P1433
P1476
mRNA translation regulation by the Gly-Ala repeat of Epstein-Barr virus nuclear antigen 1
@en
P2093
Anastassia Komarova
Chrysoula Daskalogianni
Laurence Malbert-Colas
Robin Fåhraeus
Sebastien Apcher
P2860
P304
P356
10.1128/JVI.01369-08
P407
P577
2008-11-19T00:00:00Z